Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 4/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | PRKD3 | O94806 | 3/20 | 0.34 |
| ▸ | PRKCG | P05129 | 3/20 | 0.34 |
| ▸ | PRKCB | P05771 | 3/20 | 0.34 |
| ▸ | PRKCA | P17252 | 3/20 | 0.34 |
| ▸ | PRKCH | P24723 | 3/20 | 0.34 |
| ▸ | PRKCI | P41743 | 3/20 | 0.34 |
| ▸ | PRKCE | Q02156 | 3/20 | 0.34 |
| ▸ | PRKCQ | Q04759 | 3/20 | 0.34 |
| ▸ | PRKCZ | Q05513 | 3/20 | 0.34 |
| ▸ | PRKCD | Q05655 | 3/20 | 0.34 |
| ▸ | PRKD1 | Q15139 | 3/20 | 0.34 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6069252 | 0.93 | USP2 (0.42) | USP2CES1LMNAKDM4EDUSP3 | |
| SCHEMBL11198963 | 0.91 | USP2 (0.46) | USP2CES1LMNAKDM4EDUSP3 | |
| SCHEMBL8912364 | 0.91 | USP2 (0.46) | USP2CES1LMNAKDM4EDUSP3 | |
| SCHEMBL4786647 | 0.91 | USP2 (0.46) | USP2CES1LMNAKDM4EDUSP3 | |
| SCHEMBL11159944 | 0.91 | USP2 (0.46) | USP2CES1LMNAKDM4EDUSP3 | |
| SCHEMBL11200004 | 0.91 | USP2 (0.46) | USP2CES1LMNAKDM4EDUSP3 | |
| SCHEMBL11157696 | 0.91 | USP2 (0.46) | USP2CES1LMNAKDM4EDUSP3 | |
| SCHEMBL4786370 | 0.91 | USP2 (0.46) | USP2CES1LMNAKDM4EDUSP3 | |
| SCHEMBL4786361 | 0.91 | USP2 (0.46) | USP2CES1LMNAKDM4EDUSP3 | |
| SCHEMBL5172075 | 0.91 | USP2 (0.46) | USP2CES1LMNAKDM4EDUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4384967-A | Lubricant composition containing an alkali metal borate and a sulfur-containing polyhydroxy compound | CHEVRON RESEARCH COMPANY (US) | 1983-05-24 | — | — | US | claimed |
| US-20170029436-A1 | NEOSORAPHENS | Helmoltz-Zentrum für Infektionsforschung GmbH (DE) | 2017-02-02 | — | — | US | disclosed |
| WO-2015154883-A1 | NEOSORAPHENS | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2015-10-15 | — | — | WO | disclosed |
| US-20100080908-A1 | INK SET AND METHOD FOR FORMING IMAGE | FUJIFILM CORPORATION (JP) | 2010-04-01 | — | — | US | disclosed |
| EP-1195259-B1 | Sheet for ink jet-recording | OJI PAPER CO (JP) | 2007-04-25 | — | — | EP | disclosed |
| US-6652930-B2 | Comprises mixture of compounds such as 1,2-bis(2-hydroxyethyl thio)ethane and homo/copolymers of diallylamine compounds such as polydiallylamine hydrochloride; phthalocyanine dye adds to stability; discoloration inhibition extends shelf-life | OJI PAPER CO., LTD. (JP) | 2003-11-25 | — | — | US | disclosed |
| US-20020071941-A1 | Sheet for ink jet-recording | OJI PAPER CO., LTD. (JP) | 2002-06-13 | — | — | US | disclosed |
| EP-1195259-A2 | Sheet for ink jet-recording | OJI PAPER CO., LTD. (JP) | 2002-04-10 | — | — | EP | disclosed |
| US-4384967-A | Lubricant composition containing an alkali metal borate and a sulfur-containing polyhydroxy compound | CHEVRON RESEARCH COMPANY (US) | 1983-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170029436-A1 | NEOSORAPHENS | IL17A, RORC, CD4 | USP2 4304/4885CES1 2947/4885LMNA 4052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.